Vaccine Adjuvant Market, By Product Type (Particulate Adjuvants, Emulsion Adjuvants, Pathogen Adjuvants, Combination Adjuvants, and Other Adjuvants), By Route of Administration (Oral, Intranasal, Intramuscular, Subcutaneous, Intradermal, and Others), By Disease Type (Cancer, Infectious Disease, and Others), By Application (Research, Commercial, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI8618 | Publish Date: April 2024 | No. of Pages: 170

Global Vaccine Adjuvant Market By Overview

Vaccine Adjuvant  Market was valued at US$ 1.6 Billion in 2024 and is projected to grow at a CAGR of 12.30% to reach US$ 5.1 Billion by 2034.

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. The adjuvant helps to activate the immune system that allows the antigens-pathogen components to elicit an immune response in vaccines to induce long-term protective immunity. 

Therefore, many market players are majorly investing in research and development for development of safe and effective vaccine adjuvants, which is expected to favor the growth of vaccine adjuvant market. 

Further, the increasing prevalence of naïve infectious chronic diseases overall the globe is also the major factor to drive the vaccine adjuvant market

Moreover, the factors such as support of government in research and development, is also expected to propel the vaccine adjuvant market. 

The manufactures are also involved in acquisitions, collaboration and merger for product launch is also expected to favor the vaccine adjuvant market. 

However, stringent regulatory policy for approval of vaccine adjuvant products besides high cost of production, manufacturing complexities, and various safety concerns hampers the growth of the vaccine adjuvant market.

Vaccine Adjuvant Market is segmented on the basis of product type, route of administration, disease type, application and region. 

On the basis of product type, the global vaccine adjuvant has been segmented into emulsions adjuvants, particulate adjuvants, pathogen adjuvants, combination adjuvants, and others adjuvants.

On the basis of route of administration the global vaccine adjuvant market is segmented into oral, intranasal, intramuscular, intradermal, others. 

Further, on the basis of disease type, the global vaccine adjuvant market is segmented into cancer, infectious disease and others. 

On the basis of application the global vaccine adjuvant market is segmented into research, commercial and others. 

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the market of vaccine adjuvant include SEPPIC Inc., Novavax, Inc., Hayashibara Co., Ltd., SPI Pharma Inc, Invivogen, Avanti Polar Lipids, Inc., MPV Technologies, OZ Biosciences, Agenus,Inc., Brenntag Biosector, Spectrum Pharmaceuticals. Inc., Sigma Aldrich, Adjuatis, Vaxliant, Adjuvance Technologies, Inc., GlaxoSmithKline plc., Puma Biotechnology, Tj Kaiwei, Zhouyue, Aphios, and CSL Limited.

Global Vaccine Adjuvant Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Disease Type
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Product Type, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Particulate Adjuvants
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Emulsion Adjuvants
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Pathogen Adjuvants
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Combination Adjuvants
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Route of Administration, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Intranasal
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Intramuscular
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Subcutaneous
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Intradermal
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Disease Type, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Cancer
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Infectious Disease
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application , Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Research
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Commercial
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Route of Administration, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  2. Company Profiles
  • Populous
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • SEPPIC INC.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies            
    •  
  • NOVAVAX INC.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • HAYASHIBARA CO, Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • SPI Pharma INC.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sigma Aldrich
    • Company Overview
    • Product Portfolio
    • Key Highlights                                                                            
    • Financial Performance
    • Business Strategies
  • Vaxliant
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Puma Biotechnology
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Tj Kaiwei
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Zhouyue
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Vaccine Adjuvant Market is segmented on the basis of product type, route of administration, disease type, application and region.

The increasing prevalence of naïve infectious chronic diseases overall the globe is also the major factor to drive the vaccine adjuvant market.

Key players operating in the global market of vaccine adjuvant include SEPPIC Inc., Novavax, Inc., Hayashibara Co., Ltd., SPI Pharma Inc, Invivogen, Avanti Polar Lipids, Inc., MPV Technologies, OZ Biosciences, Agenus,Inc., Brenntag Biosector, Spectrum Pharmaceuticals. Inc., Sigma Aldrich, Adjuatis, Vaxliant, Adjuvance Technologies, Inc., GlaxoSmithKline plc., Puma Biotechnology, Tj Kaiwei, Zhouyue, Aphios, and CSL Limited.

North America is expected to account major market share as compared to that of other regions.

Stringent regulatory policy for approval of vaccine adjuvant products besides high cost of production, manufacturing complexities, and various safety concerns hampers the growth of the vaccine adjuvant market.